Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy

Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients. <i>RAS</i> and <i>BRAF</i> inhibitors have been developed for patients who become unresponsive to standar...

Full description

Bibliographic Details
Main Authors: Gerardo Rosati, Giuseppe Aprile, Alfredo Colombo, Stefano Cordio, Marianna Giampaglia, Alessandro Cappetta, Concetta Maria Porretto, Alfonso De Stefano, Domenico Bilancia, Antonio Avallone
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
metastatic colorectal cancer
precision medicine
<i>RAS</i> and <i>BRAF</i> inhibitors
immunotherapy
anti-<i>HER-2</i>
<i>TRK</i> inhibitors
Online Access:https://www.mdpi.com/2227-9059/10/5/1035

Internet

https://www.mdpi.com/2227-9059/10/5/1035

Similar Items